Financials
Financial year 2024
LYSEMED from Brussel, company number BE0800217930, closed financial year 2024 with a result of € 339,873 after tax. For that financial year LYSEMED recorded a gross margin of € 484,430 and equity of € 558,440. Compared with financial year 2023, the result moved from € 215,567 to € 339,873. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.
€ 558,440
▲ 156% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 339,873
▲ 58% vs 2023
Profit after tax over the fiscal year.
€ 242,309
▲ 28% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 555,440.
People and assets in 2024
€ 82,174
▼ 3% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 67,071
▼ 21% vs 2023
€ 18,421 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 630
▼ 73% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 112,205
▲ 66% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 301,870 | € 484,430 | ▲ 60% |
| Profit after taxes | € 215,567 | € 339,873 | ▲ 58% |
| Equity | € 218,567 | € 558,440 | ▲ 156% |
| Total debts | € 155,964 | € 179,970 | ▲ 15% |
| Cash | € 188,910 | € 242,309 | ▲ 28% |
| Retained profit | € 215,567 | € 555,440 | ▲ 158% |
| Bank debt | € 84,821 | € 67,071 | ▼ 21% |
| Balance sheet total | € 374,531 | € 738,409 | ▲ 97% |
Key figures of LYSEMED, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to LYSEMED?
What happened at LYSEMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 339,873 (▲ 58% vs 2023). filed late Source: NBB ↗
- Edrissi Arani Molly became a director. NBB
- New establishment in Oudergem. KBO
- Sanak Serdal became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 215,567 profit in 2023 to € 339,873 profit in 2024.
Paid € 179,879 in corporate taxes since 2023.
Best year ever: 2024, with € 339,873 profit.
A new publication or filing at LYSEMED? We notify you, reason included.
Follow LYSEMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind LYSEMED are Sanak Serdal and Edrissi Arani Molly.
Directors
According to the 2024 annual accounts
Sanak Serdal
Director
since 2023
Edrissi Arani Molly
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Kongolaan 16 box 22
1000 Brussel
Albert Crommelynckgaarde 6 box 2
1160 Oudergem
Active since 31 March 2023
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0800.217.930
- VAT number
- BE 0800.217.930
- Registered office
- Kongolaan 16 bus 22, 1000 Brussel
- Names & denominations
- LYSEMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 March 2023
- Peppol
- Active · Active since 4 Feb 2026
- Contact
- [email protected] +32492515253